These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18633610)

  • 21. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.
    Yamano T; Kaneda Y; Huang S; Hiramatsu SH; Hoon DS
    Mol Ther; 2006 Jan; 13(1):194-202. PubMed ID: 16112911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells.
    Roberts DJ; Franklin NA; Kingeter LM; Yagita H; Tutt AL; Glennie MJ; Bullock TN
    J Immunother; 2010 Oct; 33(8):769-79. PubMed ID: 20842060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment and prevention of mouse melanoma with an oral DNA vaccine carried by attenuated Salmonella typhimurium.
    Zhu X; Cai J; Huang J; Jiang X; Ren D
    J Immunother; 2010 Jun; 33(5):453-60. PubMed ID: 20463603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.
    Gray JE; Chiappori A; Williams CC; Tanvetyanon T; Haura EB; Creelan BC; Kim J; Boyle TA; Pinder-Schenck M; Khalil F; Altiok S; Devane R; Noyes D; Mediavilla-Varela M; Smilee R; Hopewell EL; Kelley L; Antonia SJ
    Cancer Immunol Immunother; 2018 Dec; 67(12):1853-1862. PubMed ID: 30209589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor.
    Guiducci C; Di Carlo E; Parenza M; Hitt M; Giovarelli M; Musiani P; Colombo MP
    J Immunol; 2004 Apr; 172(7):4026-36. PubMed ID: 15034014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth.
    Loeffler M; Le'Negrate G; Krajewska M; Reed JC
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12879-83. PubMed ID: 17652173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
    Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
    Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic vaccines based on genetically modified Salmonella: a novel strategy in cancer immunotherapy.
    Chorobik P; Marcinkiewicz J
    Pol Arch Med Wewn; 2011 Dec; 121(12):461-6. PubMed ID: 22129784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-targeted Salmonella as a novel anticancer vector.
    Pawelek JM; Low KB; Bermudes D
    Cancer Res; 1997 Oct; 57(20):4537-44. PubMed ID: 9377566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-tumor effect and impact on tumor immune microenvironment of tumor-targeted Salmonella VNP20009].
    Han YH; Lai XH; Le ZW; Hua ZC
    Yao Xue Xue Bao; 2016 Sep; 51(9):1417-22. PubMed ID: 29924525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
    Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
    Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo.
    Wu YG; Wu GZ; Wang L; Zhang YY; Li Z; Li DC
    Med Oncol; 2010 Sep; 27(3):736-42. PubMed ID: 19669608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel approach to improve immune effector responses post transplant by restoration of CCL21 expression.
    Stefanski HE; Jonart L; Goren E; Mulé JJ; Blazar BR
    PLoS One; 2018; 13(4):e0193461. PubMed ID: 29617362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.
    Chen P; Luo S; Wen YJ; Li YH; Li J; Wang YS; Du LC; Zhang P; Tang J; Yang DB; Hu HZ; Zhao X; Wei YQ
    Cancer Sci; 2014 Nov; 105(11):1393-401. PubMed ID: 25230206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
    Winter H; Hu HM; McClain K; Urba WJ; Fox BA
    J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10.
    Lu XL; Jiang XB; Liu RE; Zhang SM
    Vaccine; 2008 Oct; 26(42):5352-7. PubMed ID: 18723067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
    Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    Blood; 2002 Nov; 100(9):3155-63. PubMed ID: 12384413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.
    Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8
    Murakami T; Hiroshima Y; Zhang Y; Zhao M; Kiyuna T; Hwang HK; Miyake K; Homma Y; Mori R; Matsuyama R; Chishima T; Ichikawa Y; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Cell Biochem; 2018 Jan; 119(1):634-639. PubMed ID: 28628234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.